Skip Navigation



Rheumatology Advance Access published online on June 6, 2007

Rheumatology, doi:10.1093/rheumatology/kem107
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/8/1329    most recent
kem107v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mohammad, A. J.
Right arrow Articles by Segelmark, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohammad, A. J.
Right arrow Articles by Segelmark, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg–Strauss syndrome within a defined population in southern Sweden

A. J. Mohammad1,2, L. T. H. Jacobsson3, A. D. Mahr4, G. Sturfelt5 and M. Segelmark1

1Department of Nephrology, Lund University Hospital, Lund, 2Department of Internal Medicine, Helsingborg Hospital, Helsingborg, 3Department of Rheumatology, Malmö University Hospital, Malmö, Sweden, 4Department of Internal Medicine, Hôpital Cochin, Université Paris, Paris, France and 5Department of Rheumatology, Lund University Hospital, Lund, Sweden

Correspondence to: Aladdin J. Mohammad, Department of Nephrology, Lund University Hospital, S-221 85 Lund, Sweden. E-mail: aladdin.mohammad{at}med.lu.se


   Abstract

Objectives. To estimate the point prevalence (p.p.) of Wegener's granulomatosis (WG), microscopic polyangiitis (MPA), polyarteritis nodosa (PAN) and Churg–Strauss syndrome (CSS) within a defined population in southern Sweden.

Method. A cross-sectional p.p. study using multiple sources for case identification. The study area, a healthcare district around the city of Lund in southern Sweden (Mellersta Skånes sjukvårdsdistrikt), had, on 31 December 2002, a total population of 287 479 inhabitants. All the identified cases were verified by medical record review. The patients were classified according to an algorithm based on the American College of Rheumatology classification criteria 1990 and the Chapel Hill Consensus Conference definitions 1994.

Results. Eighty-six patients (49% female) with a median age of 64.8 yrs (range 15–90.5) fulfilled the study criteria. There were 46 patients with WG; 27 with MPA; nine with PAN; and four with CSS. The p.p. per million inhabitants was estimated on 1 January 2003 to be 160 (95% confidence interval 114–206) for WG, 94 (58–129) for MPA, 31 (11–52) for PAN and 14 (0.3–27) for CSS. Capture–recapture analysis estimated the completeness of the case finding to 96%.

Conclusions. The prevalence of WG, MPA, PAN and CSS in our district is the highest figure reported so far. Explanations for this finding may include high incidence, extensive ANCA-testing, good survival as well as sensitive search methods for case identification.

KEY WORDS: Vasculitis, Arteritis, ANCA, Prevalence, Wegener's granulomatosis

Submitted 24 November 2006; revised version accepted 21 March 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
A. J. Mohammad, L. T. H. Jacobsson, K. W. A. Westman, G. Sturfelt, and M. Segelmark
Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa
Rheumatology, December 1, 2009; 48(12): 1560 - 1565.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. E. Wechsler, D. A. Wong, M. K. Miller, and L. Lawrence-Miyasaki
Churg-Strauss Syndrome in Patients Treated With Omalizumab
Chest, August 1, 2009; 136(2): 507 - 518.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.